Combined with the result that NDRG1 could not affect the expression of EGFR at mRNA level (Fig. 2A), we speculated that NDRG1 may regulate EGFR protein translation and/or post-translational modifications and consequently alter the sensitivity of CRC cells to CTX. The gene discussed is EGFR; the disease is colorectal carcinoma.